The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

• Hauptverfasser: A. Tyndall (Verfasst von), S. Urbani (Verfasst von), S. Guidi (Verfasst von), A. Bosi (Verfasst von), S. Guiducci (Verfasst von), F. Pagliai (Verfasst von), R. Saccardi (Verfasst von), I. Miniati (Verfasst von), M. Matucci Cerinic (Verfasst von)
• Format: Buch
• Veröffentlicht: PAGEPress Publications, 2011-09-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Objectives: Autologous hematopoietic stem cell transplantation (HSCT) is a treatment option which may be considered for severe diffuse cutaneous systemic sclerosis (dcSSc) patients not responding to cyclophophamide (CY). We present two cases of dcSSc not responding to CY >10 g who were successful...